Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Dow
Medtronic
Colorcon
AstraZeneca

Last Updated: October 2, 2022

Investigational Drug Information for Gefarnate


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Gefarnate?

Gefarnate is an investigational drug.

There have been 4 clinical trials for Gefarnate. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2007.

The most common disease conditions in clinical trials are Stomach Ulcer, Duodenal Ulcer, and Ulcer. The leading clinical trial sponsors are Takeda, Gastro-Intestinal Medical Care Research Center, and Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.

Recent Clinical Trials for Gefarnate
TitleSponsorPhase
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual HypertriglyceridemiaFirst Affiliated Hospital of Harbin Medical UniversityPhase 2/Phase 3
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse EvaluationGastro-Intestinal Medical Care Research CenterPhase 3
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse EvaluationTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanPhase 3

See all Gefarnate clinical trials

Clinical Trial Summary for Gefarnate

Top disease conditions for Gefarnate
Top clinical trial sponsors for Gefarnate

See all Gefarnate clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Dow
Medtronic
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.